“FrailtyLinkedWithHigherRiskOfSeriousInfectionsHospitalizationsInRheumatoidArthritisPatientsTreatedWithBiologicOrTargeted-SyntheticDMARDs”

https://pubmed.ncbi.nlm.nih.gov/38116680

Frailty is associated with increased risk of serious infections and hospitalizations in rheumatoid arthritis patients treated with biologic or targeted-synthetic DMARDs.